Brea, California, March 31, 2016 – PharMedQuest is excited to announce the signing of a new ARC™ Client, expanding its presence into new markets outside of California. Authorization Request Coordination, also known as ARC™, is a proprietary software management platform developed by PharMedQuest which will help service more than 50,000 Medicare patients for a key Medicare Advantage payer.
“We will provide clinical and operational support beginning in April for our Client, starting with oncology drugs and phasing in other key therapies addressing auto-immune diseases (e.g. Rheumatoid Arthritis, Crohn’s, and Multiple Sclerosis) and other high-cost specialty drugs,” said Kirby Eng, VP of Business Development for PharMedQuest and the ARC™ program.
ARC™ works collaboratively with payers and providers to optimize the clinical, operational and financial outcomes for specialty drugs processed through the Medical Benefit, which accounts for 50% of the U.S. specialty drug spend.
More information on the ARC™ program here: http://www.pharmedquest.com/arc/
PharMedQuest is a national leader in providing proven cost-effective solutions to some of the most challenging issues in healthcare. We are dedicated to providing transparent and innovative drug management solutions that optimize the clinical, operational and financial complexities of medical specialty drug management for cancer and other complex and rare diseases.
With over 20 years of Experience, PharMedQuest delivers Insight and Value to its Clients through its services, which include holistic Medical Benefit drug management, real-time access to integrated drug utilization and financial metrics and intelligence, comprehensive 340B management, and many other integrated Pharmacy and Medical solutions that go beyond traditional PBM, Specialty Pharmacy, or Utilization Management tools. For more information about PharMedQuest services, call (714) 364-4008 or visit www.PharMedQuest.com.